Treatment of Preseptal Cellulitis
For mild to moderate preseptal cellulitis, treat with oral antibiotics targeting beta-hemolytic streptococci—specifically penicillin, amoxicillin, dicloxacillin, or cephalexin for 5 days, extending treatment only if no improvement occurs within this period. 1
First-Line Antibiotic Selection
Outpatient Treatment (Mild to Moderate Cases)
- Oral antibiotics active against streptococci are the cornerstone of therapy, including penicillin, amoxicillin, dicloxacillin, or cephalexin 1
- For pediatric patients with preseptal cellulitis associated with acute bacterial sinusitis (eyelid <50% closed), high-dose amoxicillin-clavulanate provides comprehensive coverage 1
- For penicillin-allergic patients, use clindamycin or erythromycin 1
- Standard treatment duration is 5 days, extending only if clinical improvement has not occurred 1
When to Consider MRSA Coverage
MRSA coverage is not routinely indicated for typical preseptal cellulitis. However, consider adding vancomycin or another anti-MRSA agent when: 1
- Penetrating trauma is present
- Evidence of MRSA infection elsewhere
- Known nasal colonization with MRSA
- History of injection drug use
- Purulent drainage is present
Hospitalization Criteria and Severe Cases
Hospitalize patients who meet any of the following criteria: 1
- Systemic inflammatory response syndrome (SIRS)
- Altered mental status or hemodynamic instability
- Concern for deeper infection or orbital involvement
- Immunocompromised status
- Failed outpatient treatment
Severe Infection Management
- For severe infections requiring hospitalization, use vancomycin or another antimicrobial effective against both MRSA and streptococci 1
- In neonates requiring intravenous therapy, administer antibiotics over 60 minutes to reduce the risk of bilirubin encephalopathy 1
- Appropriate antimicrobial therapy for intraorbital complications includes vancomycin to cover possible methicillin-resistant S. pneumoniae 1
Pediatric-Specific Considerations
- Treatment approach for children mirrors adults, with antibiotics active against streptococci 1
- Oral options for outpatient treatment include penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cefalexin, or clindamycin 1
- If proptosis, impaired visual acuity, or impaired/painful extraocular mobility develops, immediately hospitalize and perform contrast-enhanced CT 1
- Daily follow-up is mandatory until definite improvement is noted 1
- Consultation with otolaryngology, ophthalmology, and infectious disease is appropriate for guidance regarding surgical intervention and antimicrobial selection 1
Adjunctive Measures
- Elevate the affected area to promote gravity drainage of edema—this is critical and failure to do so delays improvement 1
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adult patients to hasten resolution 1
Monitoring and Follow-Up
- Patients should show improvement within 24-48 hours of appropriate antibiotic therapy 1
- If no improvement occurs within 72 hours, take the following actions: 1
- Consider changing antibiotics
- Obtain imaging to rule out orbital involvement or abscess formation
- Admit for intravenous antibiotics
- C-reactive protein >120 mg/L suggests orbital rather than preseptal involvement and warrants CT imaging 2
Prevention of Recurrence
- Identify and treat predisposing conditions such as sinusitis, edema, and toe web abnormalities 1
- For patients with 3-4 episodes per year despite addressing predisposing factors, consider prophylactic antibiotics such as oral penicillin or erythromycin twice daily for 4-52 weeks 1
Common Pitfalls to Avoid
- Not elevating the affected area, which significantly delays improvement 1
- Inadequate treatment duration when clinical improvement is not evident after 5 days 1
- Empirically covering MRSA without specific risk factors 1
- Failing to recognize that diplopia, ophthalmoplegia, and proptosis indicate orbital (not preseptal) cellulitis and require immediate CT imaging 2
- Using fluoroquinolones as first-line therapy—while one case report showed response to ciprofloxacin for Proteus species 3, these agents have inadequate streptococcal coverage for typical preseptal cellulitis